Albany, New York, February 01, 2016: Market Research Reports Search Engine (MRRSE) has announced that its repository now features a report titled “Preimplantation Genetic Diagnosis Market (Test Type – PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020”. The report, by Transparency Market Research, forecasts that the global preimplantation genetic diagnosis market stood at US$77.2 mn in 2013 and is predicted to reach US$118 mn by 2020. The market will expand at a 6.28% CAGR from 2014 to 2020. This study presents a detailed analysis of the global preimplantation genetic diagnosis (PGD) market and also presents the upcoming and current growth trends for elucidating the substantial investment pockets in the market. The current and upcoming trends are outlined in order to determine the attractiveness of the market and for acquainting the readers with the most promising trends to attain a strong position within the market.
The introductory part of the report discusses PGD processes and applications and also throws light on the chief market dynamics within the market. These market dynamics include the prominent market drivers, impeders, opportunities, and challenges in the market. The report states that PGD is highly demanded by women of higher age groups owing to delays experienced in conceiving. In addition, the rising occurrence of genetic diseases forces patients to go for PGD cycles. Furthermore, the rising hazards related to stress, pollution, and increasing levels of smoking have resulted in the decreased fertility of women, thus raising the demand for PGD. On the other hand, as per the report, the limited coverage of insurance for PGD leads to its lower demand, thus restraining the growth of the market.
Browse Full Global Preimplantation Genetic Diagnosis Market Report with TOC: http://www.mrrse.com/preimplantation-genetic-diagnosis-market
Next in the report, the PGD market is segmented on the basis of test type into aneuploidy screening, X-linked diseases, PGD for chromosomal aberrations, single gene disorders, gender selection, and HLA typing. Amongst these, in 2013, the segment of aneuploidy screening led the market owing to the fact that aneuploidy may result in severe abnormalities. In terms of geography, the report segments the market into Asia Pacific, North America, and Rest of the World (RoW). Amongst these, in 2013, Europe held the largest share in the market owing to the rising count of IVF cycles performed in this region. On the other hand, North America is predicted to exhibit the highest CAGR in the forecast horizon due to the increasing rate of disabilities in this region.
As stated in this study, the prime vendors dominant in the market for preimplantation genetic diagnosis are Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC, and Reproductive Genetics Institute.
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207